Vitamin D deficiency in women with polycystic ovarian syndrome- a cross-sectional observational study in Indian subcontinent

Neha Tomar; Aman Deep Raj; Suvendu Kumar Nayak

doi:10.18203/2320-1770.ijrcog20260890

Authors

Neha Tomar Department of Obstetrics and Gynaecology, Military Hospital Jammu, Jammu and Kashmir, India
Aman Deep Raj Department of Obstetrics and Gynaecology, Military Hospital Jammu, Jammu and Kashmir, India https://orcid.org/0000-0001-5088-8106
Suvendu Kumar Nayak Department of Obstetrics and Gynaecology, BHDC, New Delhi, India https://orcid.org/0009-0008-3924-8341

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20260890

Keywords:

Polycystic ovary syndrome, Insulin resistance, Metabolic syndrome, Hyperandrogenism, HOMA-IR, Women health, Vitamin D deficiency

Abstract

Background: Polycystic Ovarian Syndrome (PCOS) affects up to 18% of reproductive-age women, presenting with menstrual dysfunction, hirsutism, and metabolic complications. Vitamin D deficiency (VDD) shares features such as insulin resistance and obesity. Although global studies link hypovitaminosis D to metabolic risk, evidence in Indian women remains limited and inconsistent. This study assessed the prevalence of VDD and its association with metabolic and endocrine parameters in Indian women with PCOS.

Methods: A cross-sectional study was conducted at Army Hospital Research and Referral, New Delhi, over 18 months (February 2022-February 2024). A total of 170 women (18-40 years) diagnosed with PCOS by Rotterdam criteria were enrolled. Participants were stratified by serum 25-hydroxyvitamin D (25(OH)D) levels: Group I (<30ng/ml) and Group II (≥30 ng/ml). Evaluations included anthropometry (BMI, waist circumference), hormonal profiles (LH, FSH, AMH, TSH), and metabolic markers (fasting glucose, insulin, HOMA-IR, HbA1c, cholesterol).

Results: Most participants (89.4%, n=152) had suboptimal Vitamin D levels, while only 10.6% (n=18) were sufficient. Comparative analysis showed no significant differences (p>0.05) between groups in age, menstrual irregularities, Ferriman-Gallwey scores, ovarian morphology, or biochemical markers (LH, FSH, AMH, insulin, HOMA-IR, BMI). Spearman correlation confirmed no significant linear association between 25(OH)D levels and metabolic or hormonal variables.

Conclusions: Hypovitaminosis D is highly prevalent among Indian women with PCOS. However, Vitamin D status did not significantly influence metabolic or endocrine dysfunction in this cohort, suggesting it may represent a comorbid condition rather than a causal factor. Larger longitudinal studies are warranted to clarify causal pathways and therapeutic relevance.

Metrics

Metrics Loading ...

References

Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al., Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28-38. DOI: https://doi.org/10.1016/j.fertnstert.2011.09.024

Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007 ;370(9588):685-97. DOI: https://doi.org/10.1016/S0140-6736(07)61345-2

Singh S, Gori P, Patel P, Paul A. Comprehensive Overview of PCOS: Exploring Etiology, Diagnosis, and Treatment Approaches. Curr Pharmacol Rep. 2025;11(1):39. DOI: https://doi.org/10.1007/s40495-025-00419-w

Chandrasekaran S, Sagili H. Metabolic syndrome in women with polycystic ovary syndrome. Obstet Gynaecol. 2018;20(4):245-52. DOI: https://doi.org/10.1111/tog.12519

He LP, Li CP, Liu CW, Gu W. The Regulatory Effect of Vitamin D on Pancreatic Beta Cell Secretion in Patients with Type 2 Diabetes. Curr med chem. 2024;32. DOI: https://doi.org/10.2174/0109298673270429240805050928

Morró M, Vilà L, Franckhauser S, Mallol C, Elias G, Ferré T,et al. Vitamin D Receptor Overexpression in β-Cells Ameliorates Diabetes in Mice. Diabetes. 2020;69(5):927-39. DOI: https://doi.org/10.2337/db19-0757

Malaisse WJ, Lebrun P, Herchulez A. Calcium Regulation of Insulin Release. In: Marmé, D. (eds) Calcium and Cell Physiology. Springer; Berlin, Heidelberg. 1985;221-36. DOI: https://doi.org/10.1007/978-3-642-70070-5_15

Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, et al., Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013;12(10):976-89. DOI: https://doi.org/10.1016/j.autrev.2013.02.004

Morgante G, Darino I, Spanò A, Luisi S, Luddi A, Piomboni P, et al. PCOS Physiopathology and Vitamin D Deficiency: Biological Insights and Perspectives for Treatment. J Clin Med. 2022; 11(15):4509. DOI: https://doi.org/10.3390/jcm11154509

Mogili KD, Karuppusami R, Thomas S, Chandy A, Kamath MS, Aleyamma TK. Prevalence of vitamin D deficiency in infertile women with polycystic ovarian syndrome and its association with metabolic syndrome – A prospective observational study. Eur J Obstet Gynecol Reprod Biol. 2018;229:15-9. DOI: https://doi.org/10.1016/j.ejogrb.2018.08.001

Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR, et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol. 2009;161(4):575-82. DOI: https://doi.org/10.1530/EJE-09-0432

Li HW, Brereton RE, Anderson RA, Wallace AM, Ho CK. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism. 2011 ;60(10):1475-81. DOI: https://doi.org/10.1016/j.metabol.2011.03.002

Kim JJ, Choi YM, Chae SJ, Hwang KR, Yoon SH, Kim MJ, et al. Vitamin D deficiency in women with polycystic ovary syndrome. Clin Exp Reprod Med. 2014;41(2):80-5. DOI: https://doi.org/10.5653/cerm.2014.41.2.80

Balogh Z, Csehely S, Orosz M, Bhattoa HP, Krasznai ZT, Deli T,et al. Relations of Insulin Resistance, Body Weight, Vitamin D Deficiency, SHBG and Androgen Levels in PCOS Patients. Biomedicines. 2025;13(8):1803. DOI: https://doi.org/10.3390/biomedicines13081803

Siddiqee MH, Bhattacharjee B, Siddiqi UR. High prevalence of vitamin D deficiency among the South Asian adults: a systematic review and meta-analysis. BMC Public Health. 2021;21:1823. DOI: https://doi.org/10.1186/s12889-021-11888-1

He C, Lin Z, Robb SW, Ezeamama AE. Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis. Nutrients. 2015;7:4555-77. DOI: https://doi.org/10.3390/nu7064555

Franks S. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril. 2004;81(1):19-25. DOI: https://doi.org/10.1016/j.fertnstert.2003.10.004

Bani Mohammad M, Majdi Seghinsara A. Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH. Asian Pac J Cancer Prev. 2017;18(1):17-21.

Neelaveni K, Himaja K, Srinivas Rao P, Rakesh Kumar S. Vitamin D levels in PCOS women and correlation with metabolic parameters. Int J Clin Obstet Gynaecol. 2019;3(6):87-91. DOI: https://doi.org/10.33545/gynae.2019.v3.i6b.396

Wang L, Wang H, Wen H, Tao H, Zhao X. Relationship between HOMA-IR and serum vitamin D in Chinese children and adolescents. J pediatr endocrinol metab. 2016;29(7):777-81. DOI: https://doi.org/10.1515/jpem-2015-0422

Gokosmanoglu F, Onmez A, Ergenç H. The relationship between Vitamin D deficiency and polycystic ovary syndrome. Afr health sci. 2020;20(4):1880-6. DOI: https://doi.org/10.4314/ahs.v20i4.45

Pal L, Berry A, Coraluzzi L, Kustan E, Danton C, Shaw J, et al. Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecol endocrinol. 2012;28(12):965-8. DOI: https://doi.org/10.3109/09513590.2012.696753